Abstract
The title compound was synthesized, characterized by1H nmr, and crystallized for x-ray crystallography. The antimuscarinic potency of the title compound was about equipotent to aprophen or atropine in inhibiting acetylcholine-induced contraction of guinea pig ileum (K B =4.5 nM) and in inhibiting carbachol-stimulated release ofα-amylase from rat pancreatic acinar cells (K i =1.4nM), and in inhibiting the binding of [N-methyl-3H]scopolamine to cerebral cortex (K i =6.6nM). In the crystal, the O-C-C-C-N+ segment adopted a gauche-gauche configuration resulting in an N+⋯O (carbonyl) distance of 5.001(9)Å, a distance comparable to that in aprophen. The ether oxygen atom is buried rendering it inaccessible for interaction with the muscarinic receptor. The carbonyl oxygen atom is exposed to the surface of the molecule and is readily accessible for intermolecular interactions. The similarity in biological activities of the title compound and aprophen is congruous with their similar N+⋯O (carbonyl) distances.
Similar content being viewed by others
References
Cheng, Y.-C., and Prusoff, W. H. (1973)Biochem. Pharmacol. 22, 3099.
Flavin, M. T., Lu, C. M., Thompson, E. B., and Bhargava, H. N. (1987)J. Med. Chem. 30, 278.
Gordon, R. K., Breuer, E., Padilla, F. N., Smejkal, R. M., and Chiang, P. K. (1989)Mol. Pharmacol. 36, 766.
Guy, J. J., and Hamor, T. A. (1973)J.C.S. Perkin II, 942.
Guy, J. J., and Hamor, T. A. (1974)Acta Crystallogr. B 30, 2277.
Karle, J., and Karle, I. L. (1966)Acta Crystallogr. 21, 849.
Karle, J. M., Karle, I. L., and Chiang, P. K. (1990)Acta Crystallogr. B 46, 215.
Karle, J. M., Karle, I. L., Gordon, R. K., and Chiang, P. K. (1992)Acta Crystallogr. in press.
Leader, H., Smejkal, R. M., Payne, C. S., Padilla, F. N., Doctor, B. P., Gordon, R. K., and Chiang, P. K. (1989)J. Med. Chem. 32, 1522.
Munson, P. J., and Rodbard D. (1979)Endocrinology 105, 1377.
Peralta, E. G., Ashkenazi, A., Winslow, J. W., Smith, D. H., Ramchandran, J., and Capon, D. J. (1987)EMBO J. 6, 3923.
Petcher, T. J. (1974)J. C. S. Perkin II, 1151.
Sheldrick, G. M. (1985) inCristallographic Computing 3, G. M. Sheldrick, C. Krüger and R. Goddard (eds.) (Oxford Univ. Press), p. 175.
Tallarida, R. J., Cowan, A., and Adler, M. W., (1979)Life Sci. 25, 537.
Tollenaere, J. P., Moereels, H., and Raymaekers, L. A.Atlas of the three-dimensional structure of drugs (Elsevier/North-Holland Biomedical Press, Amsterdam, 1979).
Author information
Authors and Affiliations
Additional information
National Research Council Senior Associate, on leave from the Department of Organic Chemistry, Israel Institute for Biological Research, Ness Ziona, Israel.
National Research Council Senior Associate, on leave from the Department of Pharmaceutical Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel.
Rights and permissions
About this article
Cite this article
Karle, J.M., Karle, I.L., Leader, H. et al. Relationship of the crystal structure of γ-N,N-dimethylaminopropyl 2,2-diphenylpropionate hydrochloride to antimuscarinic activity. Journal of Crystallographic and Spectroscopic Research 22, 485–491 (1992). https://doi.org/10.1007/BF01195411
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01195411